Skip to main content

Pay Bill Portals

Our Tests
Our Services
- - Oncology
    - - SERVICES
        
        NateraCore Services
        
        Pharma Partnership
        
        Real-World Data
        
        EMR Integration
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
        
        Contact Us
    - - FOR CLINICIANS
        
        Schedule Session With Client Services
        
        Oncology Portal
        
        Order a Test Kit
        
        Contact Us
  - Organ Health
    - - SERVICES
        
        NateraCore Services
        
        ProReach
        
        EMR Integration
        
        Pharma Services
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Order a Renasight Kit
        
        Contact Us
        
        Pricing and Billing Information
    - - FOR CLINCIANS
        
        Organ Health Portal
        
        Order a Renasight Kit
        
        Contact Us
  - Women’s Health
    - - SERVICES
        
        NateraCore Services
        
        Constellation
        
        EMR Integration
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
        
        Women’s Health Portal
        
        Contact Us
    - - FOR CLINICIANS
        
        Order Tests and Track Status on NateraConnect
        
        View Patient Results on NateraConnect
        
        Contact Us
Patient Resources
- - Oncology
    - - LEARN
        
        Signatera
        
        Altera
        
        Empower
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Organ Health
    - - LEARN
        
        Prospera
        
        Renasight
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Women’s Health
    - - LEARN
        
        Horizon
        
        Panorama
        
        Empower
        
        Vistara
        
        Anora
        
        Spectrum
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients – USA)
        
        Schedule Blood Draw (Existing Patients – Canada)
        
        Pricing and Billing Information
        
        Women’s Health Portal
    - - CONNECT
        
        Contact Us
Clinical Resources
- - Oncology
    - - CLINICAL RESOURCES
        
        Signatera
        
        Signatera Publications
        
        Altera
        
        Empower
        
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        Signatera Research Pipeline
        
        Natera Sponsored Trials
    - - CONNECT
        
        Oncology Portal
        
        Contact Us
  - Organ Health
    - - CLINICAL RESOURCES
        
        Organ Health Publications
        
        Prospera
        
        Renasight
        
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        ProActive Study
        
        PEDAL Study
        
        Trifecta Study
        
        MOTR Study
    - - CONNECT
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - CLINICAL RESOURCES
        
        Women’s Health Publications
        
        Horizon
        
        Panorama
        
        Empower
        
        Vistara
        
        Anora
        
        Spectrum
        
        Natera Academy Provider Education Hub
        
        View All Clinician Resources
    - - RESEARCH STUDIES
    - - CONNECT
        
        Contact Us
Company
Search for:
Pay Bill

Portals
Search for:

Natera, Inc.

- Altera
- Anora
- Empower
- Horizon
- Panorama
- Prospera
- Renasight
- Signatera
- Spectrum
- Vistara
- Blog
- Videos
- Brochure
- Whitepaper
- Manual
- Poster
- Report
- Study
- Webinars
- Natera Academy

Recent Searches

Home
Signatera
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers

Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers

Huffman BM, Aushev VN, Budde GL, et al. JCO-Precision Oncology. 2022

Previous Resource

Kinetics of postoperative circulating cfDNA and impact on MRD detection rates in patients with resected stage I-III CRC

Cohen SA, Kasi PM, Aushev VN, et al.
Next Resource

Cancer - 2023 - Eroglu - Circulating tumor DNA‐based molecular residual disease detection for treatment monitoring in advanced melanoma pati

Eroglu Z, Krinshpun S, Kalashnikova E, et al. Cancer 2023

Related Content

2 days ago
Optimizing Breast Cancer Surveillance: A team approach with MRD testing

Watch Video
3 days ago
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274

Galsky MD, Gschwend JE, Milowsky MI, et al. Ann Oncol. 2025

Read More
3 days ago
Neoadjuvant immunotherapy in mismatch-repair proficient colon cancers

Tan PB, Verschoor YL, van den Berg JG, et al. Nature. 2025

Read More
11 days ago
Advancing GYN Oncology Care Using ctDNA Monitoring with Signatera™: Clinical Insights and Real-World Application

Watch Video
12 days ago
Tumor-Informed ctDNA Assay to Predict Outcome in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with PD-1

Read More
18 days ago
Leadership at Diagnosis: Quarterbacking the Path to Precision Care

Watch Video
19 days ago
Why Regular MRD Testing Matters for Ovarian Cancer Patients

Read Article
18 days ago
How MRD Testing Supports Ovarian Cancer Patients: Holly’s Story

Read Article
22 days ago
Signatera Results Patient Guide

Read More
Dr. James Duke’s Head & Neck Cancer Story

Read Article
29 days ago
Ketch Study Data 1 Sheet

Read More
26 days ago
Anj’s Breast Cancer Story

Read Article
about 1 month ago
Using Circulating Tumor DNA–Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer

Ketch et al. JCO PO 2025

Read More
about 1 month ago
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients With Resected Stages I to III Colon Ca

Cohen et al. Annals of Surgery 2025

Read More
26 days ago
MRD Testing vs. Traditional Cancer Monitoring: What’s the Difference?

Read Article
26 days ago
Understanding Hereditary Cancer Risks in Ovarian Cancer

Read Article
26 days ago
How MRD Testing Helps Monitor Ovarian Cancer Recurrence

Read Article
about 1 month ago
Target, Track, Treat: Optimizing GI Cancer Management with Molecular Residual Disease Testing

Watch Video
about 1 month ago
Meet Anj, Breast Cancer Survivor and Signatera Patient

Watch Video
about 1 month ago
Post-Treatment H&N Cancer Surveillance with ctDNA

Read More

Return to Resource Library

© Natera, Inc.

Our Tests
Our Services
Patient Resources
Clinical Resources
- Resource Library
- Provider Portals
Company
Contact

Natera Licenses
IT Security Compliance
Natera Notice of Data Collection for California Residents
HIPAA Notice of Privacy Practices
Privacy Policy
Terms of Use
Sitemap

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2025 Natera, Inc. All Rights Reserved.